clinical trial · NCT06679413
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
UCB BIOSCIENCES, Inc.·phase1·completed·n = 22
Healthy Study Participantsmidazolammetforminbupropionfenfluramine HCl
brief summary
The purpose of the study is to assess the single-dose pharmacokinetics (PK) of 3 probe drugs (midazolam, bupropion, and metformin) before and after repeat doses of ZX008
started
Dec 4, 2024
primary completion
Jun 12, 2025
completion
Jun 12, 2025
last updated
Mar 30, 2026
official title
A Phase 1, Single-Center, Repeat-Dose, Open-Label, Fixed-Sequence Drug-Drug Interaction Study of ZX008 in Healthy Male Or Female Study Participants 18 To 55 Years Of Age
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol